## Background: Thiopurines are considered first-line immunomodulators for the prevention of relapse in moderate to severe pediatric crohn's disease (cd). early introduction of thiopurines was shown in a pediatric trial to maintain steroid-free remission in 90% of patients for 18 months. in the pres
EFFICACY OF AZATHIOPRINE IN MILD OR MODERATE RELAPSE IN CROHN'S DISEASE: CLINICAL AND ENDOSCOPIC EVALUATION
β Scribed by Yuji Murakami; Toshiyuki Matsui; Fumihito Hirai; Noritaka Takatsu; Yasuhiro Takaki; Takashi Nagahama; Takashi Hisabe; Takahiro Beppu; Masaki Miyaoka; Shinichiro Maki; Masao Takeichi; Taku Nishimura; Toshiharu Ueki; Kenshi Yao
- Book ID
- 108988372
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 435 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0915-5635
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Patients with clinically active Crohn's disease (CD), defined by a Crohn's Disease Activity Index (CDAI) ΟΎ150, may have normal C-reactive protein (CRP) serum levels. In such cases, it is difficult to know whether these patients have really active disease or rather functional symptoms. Th
## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines